Results 31 to 40 of about 81,709 (149)

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema

open access: yesOrphanet Journal of Rare Diseases, 2011
Up to now alpha 1-antitrypsin (AAT) augmentation therapy has been approved only for commercial use in selected adults with severe AAT deficiency-related pulmonary emphysema (i.e.
de Serres Frederick   +2 more
doaj   +1 more source

Corticosteroid therapy augments gastroduodenal permeability to sucrose

open access: yesAmerican Journal of Gastroenterology, 1998
The aim of the present study was to investigate whether corticosteroid therapy alters gastroduodenal mucosal permeability and whether permeability alteration is associated with macroscopic mucosal damage.Eight patients taking oral corticosteroid therapy (total prednisone-equivalent dose, 1.5+/-0.1 g; duration, approximately 30 days), nine patients with
Kiziltas, S   +7 more
openaire   +5 more sources

Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies

open access: yesTherapeutic Advances in Respiratory Disease, 2010
Alpha-1 antitrypsin (AAT) deficiency is a hereditary condition characterized by low levels of AAT in plasma and hence diffusion into tissues. One of the most relevant characteristics of the disease is the development of panacinar emphysema due to an ...
Adriano R. Tonelli, Mark L. Brantly
doaj   +1 more source

Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease

open access: yesMedicina
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by reduced circulating levels and/or impaired function of alpha-1 antitrypsin (AAT), a key serine protease inhibitor, in which loss of effective antiprotease protection results in ...
Evangelia Fouka   +4 more
doaj   +1 more source

Evaluation of the Effect of Using Adipose Stem Cells in Bone Augmentation in Patients with Jaw Bone Atrophy: A Systematic Review and Meta-analysis [PDF]

open access: yesInternational Journal of Scientific Research in Dental and Medical Sciences
Background and aim: Alveolar ridge bone augmentation is required for patients receiving dental implant therapy who have atrophy of the jaw bone. The latter method does not require bone harvesting, which makes it less invasive during surgery.
Hassina Shadab   +4 more
doaj   +1 more source

The evolution of augmented reality to augment physical therapy: A scoping review

open access: yesJournal of Rehabilitation and Assistive Technologies Engineering
Augmented reality is increasingly used in health care, yet little is known about how AR is being used in physical therapy practice and what clinical outcomes could occur with technology use. In this scoping review, a broad literature review was conducted to gain an understanding of current knowledge of AR use and outcomes in physical therapy practice ...
Po-Yao Hsu, Jonas Singer, Julie J Keysor
openaire   +2 more sources

Cellular immunity augmentation in mainstream oncologic therapy

open access: yesCancer Biology & Medicine, 2017
Anticancer immunotherapy has undergone a long evolving journey for decades, and has been dramatically applied to mainstream treatments in oncology in recent 5 years. This progress represents an advanced milestone following cytotoxic medicine and targeted
Daohong Chen, Xiaoshi Zhang
doaj   +1 more source

Adenosine augmentation therapy for epilepsy [PDF]

open access: yesEpilepsia, 2010
SummaryDeficiency of the brain’s endogenous anticonvulsant adenosine is a pathologic hallmark of epilepsy. Consequently, focal adenosine augmentation therapies (AATs) constitute a rational approach for seizure suppression. Focal adenosine augmentation and resulting seizure suppression can be realized by implanting adenosine‐releasing stem cells or ...
openaire   +1 more source

Défice de alfa -1 antitripsina. A experiência do Hospital de Pulido Valente com a terapêutica de reposição Alpha -1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy

open access: yesRevista Portuguesa de Pneumologia, 2009
A alfa -1 antitripsina (AAT) e sintetizada pelo fígado, com uma semivida plasmática de 4 -5 dias. Apresenta acção inibidora das proteases, com particular afinidade para a elastase dos neutrófilos.
Carla Alves Costa, Cristina Santos
doaj  

Intervertebral Disc Repair: Current Concepts

open access: yesGlobal Spine Journal, 2020
Study Design: Review article. Objective: A review of the literature on current strategies utilized in intervertebral regeneration and repair efforts. Methods: A review of the literature and analysis of the data to provide an updated review on current ...
Derek G. Ju MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy